arsenic trioxide has been researched along with Genetic Predisposition in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Li, J; Lu, M; Shi, F; Song, H; Tan, K; Wu, J; Xiao, S; Zheng, D | 1 |
| Hu, L; Huang, L; Li, C; Meng, F; Tang, Y; Wan, K; Wang, Y; Xu, D; Zhou, J | 1 |
| El Malki, K; Faber, J; Gerhold-Ay, A; Kron, B; Lehmann, N; Neu, MA; Paret, C; Pietsch, T; Russo, A; Seidmann, L; Sommer, C; Theruvath, J; Wagner, W; Wingerter, A | 1 |
| Bajel, A; Chandy, M; Desire, S; George, B; Lakshmi, KM; Mathews, V; Rao, JG; Srivastava, A; Srivastava, VM; Viswabandya, A | 1 |
| Cui, X; Liu, T; Meng, WT; Xi, YM; Ye, XS | 1 |
1 review(s) available for arsenic trioxide and Genetic Predisposition
| Article | Year |
|---|---|
Acute promyelocytic leukemia with cryptic t(15;17) on isochromosome 17: a case report and review of literature.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Marrow Examination; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Disease Progression; Fatal Outcome; Genetic Predisposition to Disease; Humans; In Situ Hybridization, Fluorescence; Isochromosomes; Karyotype; Leukemia, Promyelocytic, Acute; Male; Molecular Diagnostic Techniques; Mutation; Oncogene Proteins, Fusion; Oxides; Phenotype; Predictive Value of Tests; Time Factors; Translocation, Genetic; Treatment Outcome; Tretinoin; Young Adult | 2015 |
1 trial(s) available for arsenic trioxide and Genetic Predisposition
| Article | Year |
|---|---|
Hepatotoxicity profile of single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia, its impact on clinical outcome and the effect of genetic polymorphisms on the incidence of hepatotoxicity.
Topics: Adult; Arsenic Trioxide; Arsenicals; Chemical and Drug Induced Liver Injury; Cohort Studies; Disease-Free Survival; Female; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Incidence; Leukemia, Promyelocytic, Acute; Liver; Liver Function Tests; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxides; Polymorphism, Genetic; Remission Induction; Risk Factors; Survival Rate; Treatment Outcome | 2006 |
3 other study(ies) available for arsenic trioxide and Genetic Predisposition
| Article | Year |
|---|---|
Arsenic trioxide extends survival of Li-Fraumeni syndrome mimicking mouse.
Topics: Animals; Arsenic Trioxide; Genes, p53; Genetic Predisposition to Disease; Humans; Li-Fraumeni Syndrome; Mice; Tumor Suppressor Protein p53 | 2023 |
Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Axin Protein; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Carcinoma, Basal Cell; Cell Survival; Child; DNA Mutational Analysis; Dose-Response Relationship, Drug; Genetic Predisposition to Disease; Hedgehog Proteins; Humans; Inhibitory Concentration 50; Magnetic Resonance Imaging; Male; Mutation; Neoplasms, Neuroepithelial; Oxides; Patched-1 Receptor; Phenotype; Polymorphism, Single Nucleotide; Precision Medicine; Predictive Value of Tests; Proto-Oncogene Proteins; Repressor Proteins; Smoothened Receptor; Tumor Cells, Cultured; Up-Regulation; Wnt Signaling Pathway; Zinc Finger Protein GLI1 | 2016 |
[Methylation of P15INK4B gene in patients with myelodysplastic syndromes and demethylating effects of drugs].
Topics: Arsenic Trioxide; Arsenicals; Azacitidine; Cyclin-Dependent Kinase Inhibitor p15; Decitabine; Disease Progression; DNA Methylation; Genetic Predisposition to Disease; Humans; Leukemia; Myelodysplastic Syndromes; Oxides | 2007 |